These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3303162)

  • 1. The management of primary lymphoma of bone.
    Mendenhall NP; Jones JJ; Kramer BS; Hudson TM; Carter RL; Enneking WF; Marcus RB; Million RR
    Radiother Oncol; 1987 Jun; 9(2):137-45. PubMed ID: 3303162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized primary malignant lymphoma of bone.
    Dubey P; Ha CS; Besa PC; Fuller L; Cabanillas F; Murray J; Hess MA; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1087-93. PubMed ID: 9169817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients.
    Beal K; Allen L; Yahalom J
    Cancer; 2006 Jun; 106(12):2652-6. PubMed ID: 16700039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of stage IE primary lymphoma of bone.
    Fairbanks RK; Bonner JA; Inwards CY; Strickler JG; Habermann TM; Unni KK; Su J
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):363-72. PubMed ID: 8276651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary non-Hodgkin's lymphoma of bone. A clinicopathologic study.
    Baar J; Burkes RL; Bell R; Blackstein ME; Fernandes B; Langer F
    Cancer; 1994 Feb; 73(4):1194-9. PubMed ID: 8313322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies].
    Hoederath A; Sack H; Stuschke M; Lampka E
    Strahlenther Onkol; 1996 Jul; 172(7):356-66; discussion 367-8. PubMed ID: 8693402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy.
    Logsdon MD; Ha CS; Kavadi VS; Cabanillas F; Hess MA; Cox JD
    Cancer; 1997 Aug; 80(3):477-88. PubMed ID: 9241082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoma presenting in bone: results of histopathology, staging, and therapy.
    Reimer RR; Chabner BA; Young RC; Reddick R; Johnson RE
    Ann Intern Med; 1977 Jul; 87(1):50-5. PubMed ID: 327894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid lymphomas stages IE and IIE: comparative results for radiotherapy only, combination chemotherapy only, and multimodality treatment.
    Vigliotti A; Kong JS; Fuller LM; Velasquez WS
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1807-12. PubMed ID: 2428787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary gastric non-Hodgkin's lymphoma stage IE and IIE.
    Lybeert ML; De Neve W; Vrints LW; Coen V; Coebergh JW
    Eur J Cancer; 1996 Dec; 32A(13):2306-11. PubMed ID: 9038614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid lymphoma. The case for combined modality therapy.
    Doria R; Jekel JF; Cooper DL
    Cancer; 1994 Jan; 73(1):200-6. PubMed ID: 8275426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B.
    Lee AY; Connors JM; Klimo P; O'Reilly SE; Gascoyne RD
    J Clin Oncol; 1997 May; 15(5):1745-53. PubMed ID: 9164181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
    Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extralymphatic involvement in diffuse non-Hodgkin's lymphoma.
    Paryani S; Hoppe RT; Burke JS; Sneed P; Dawley D; Cox RS; Rosenberg SA; Kaplan HS
    J Clin Oncol; 1983 Nov; 1(11):682-8. PubMed ID: 6422003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary non-Hodgkin's lymphoma of the bone: treatment and analysis of prognostic factors for Stage I and Stage II.
    Barbieri E; Cammelli S; Mauro F; Perini F; Cazzola A; Neri S; Bunkheila F; Ferrari S; Brandoli V; Zinzani P; Mercuri M; Bacci G
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):760-4. PubMed ID: 15183479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma.
    Maor MH; Velasquez WS; Fuller LM; Silvermintz KB
    J Clin Oncol; 1990 Feb; 8(2):266-71. PubMed ID: 1688927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of radiation therapy in localized resectable intestinal non-Hodgkin's lymphoma in children.
    Nelson DF; Cassady JR; Traggis D; Baez-Giangreco A; Vawter GF; Jaffe N; Filler RM
    Cancer; 1977 Jan; 39(1):89-97. PubMed ID: 401677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary lymphoma of bone in children: analysis of treatment results with adriamycin, prednisone, Oncovin (APO), and local radiation therapy.
    Loeffler JS; Tarbell NJ; Kozakewich H; Cassady JR; Weinstein HJ
    J Clin Oncol; 1986 Apr; 4(4):496-501. PubMed ID: 3958763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.